1
|
Pisani P, Bray F and Parkin DM: Estimates
of the world-wide prevalence of cancer for 25 sites in the adult
population. Int J Cancer. 97:72–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Arber N and Levin B: Chemoprevention of
colorectal cancer: ready for routine use? Curr Top Med Chem.
5:517–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dvory-Sobol H and Arber N:
Cyclooxygenase-2 as target for chemopreventive interventions: new
approaches. Cancer Biomark. 3:153–161. 2007.PubMed/NCBI
|
4
|
Manzano A and Pérez-Segura P: Colorectal
cancer chemo-prevention: is this the future of colorectal cancer
prevention? Scientific World Journal. 2012:327–341. 2012.
View Article : Google Scholar
|
5
|
Temraz S, Mukherji D and Shamseddine A:
Potential targets for colorectal cancer prevention. Int J Mol Sci.
14:17279–17303. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Pool-Zobel B, van Loo J, Rowland I and
Roberfroid MB: Experimental evidences on the potential of prebiotic
fructans to reduce the risk of colon cancer. Brit J Nutr. 87(Suppl
2): 273–281. 2002. View Article : Google Scholar
|
7
|
Swennen K, Courtin CM and Delcour JA:
Non-digestible oligosaccharides with prebiotic properties. Crit Rev
Food Sci Nutr. 46:459–471. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Sabater-Molina M, Larque E, Torrella F and
Zamora S: Dietary fructooligosaccharides and potential benefits on
health. J Physiol Biochem. 65:315–328. 2009. View Article : Google Scholar
|
9
|
Vargas AJ and Thompson PA: Diet and
nutrient factors in colorectal cancer risk. Nutr Clin Pract.
27:613–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Oku T, Tokunaga T and Hosoya N:
Nondigestibility of a new sweetener, ‘Neosugar’ in the rat. J Nutr.
114:1574–1581. 1984.PubMed/NCBI
|
11
|
Hidaka H, Eida T, Takizawa T, Tokunaga T
and Tashiro Y: Effects of fructooligosaccharides on intestinal
flora and human health. Bifidobacteria Microflora. 5:37–50. 1986.
View Article : Google Scholar
|
12
|
Ooi LG and Liong MT: Cholesterol-lowering
effects of probiotics and prebiotics: a review of in vivo and in
vitro findings. Int J Mol Sci. 11:2499–2522. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Maiorano AE, Piccoli RM, da Silva ES and
de Andrade Rodrigues MF: Microbial production of
fructosyltransferases for synthesis of prebiotics. Biotechnol Lett.
30:1867–1877. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
de Abreu M, Alvaro-Benito M, Sanz-Aparicio
J, Plou FJ, Fernandez-Lobato M and Alcalde M: Synthesis of
6-kestose using an efficient β-fructofuranosidase engineered by
directed evolution. Adv Synth Catal. 355:1698–1702. 2013.
View Article : Google Scholar
|
15
|
Sheu DC, Chang JY, Chen YJ and Lee CW:
Production of high-purity neofructooligosaccharides by culture of
Xanthophyllomyces dendrorhous. Bioresour Technol. 132:432–435.
2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kilian S, Kritzinger S, Rycroft C, Gibson
G and du Preez J: The effects of the novel bifidogenic
trisaccharide, neokestose, on the human colonic microbiota. World J
Microbiol Biotechnol. 18:637–644. 2002. View Article : Google Scholar
|
17
|
Lim JS, Lee JH, Kang SW, Park SW and Kim
SW: Studies on production and physical properties of neo-FOS
produced by co-immobilized Penicillium citrinum and
neo-fructosyltransferase. Eur Food Res Technol. 225:457–462. 2007.
View Article : Google Scholar
|
18
|
Linde D, Rodríguez-Colinas B, Estévez M,
Poveda A, Plou FJ and Fernández-Lobato M: Analysis of
neofructooligosaccharides production mediated by the extracellular
β-fructofuranosidase from Xanthophyllomyces dendrorhous. Biores
Technol. 109:123–130. 2012. View Article : Google Scholar
|
19
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: from innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Oshima M, Dinchuk JE, Kargman SL, Oshima
H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM:
Suppression of intestinal polyposis in Apc delta716 knockout mice
by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:803–809. 1996.
View Article : Google Scholar : PubMed/NCBI
|